BDTX
NASDAQ
US
Black Diamond Therapeutics, Inc. - Common Stock
$2.39
▲ +$0.06
(+2.58%)
Vol 535K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$138.4M
P/E
6.4
ROE
17.8%
D/E
0.00
Beta
3.28
52W
$1–$5
Wall Street Consensus
15 analysts · Apr 20265
Strong Buy
8
Buy
2
Hold
0
Sell
0
Strong Sell
86.7%
Buy Rating
Price Chart
Similar Stocks
DTIL
Precision BioSciences Inc
$100.1M
FATE
Fate Therapeutics Inc
$113.3M
SPRO
Spero Therapeutics Inc
$131.3M
CBUS
Cibus Inc
$94.5M
KLRS
Kalaris Therapeutics Inc
$141.3M
AGEN
Agenus Inc
$106.8M
EQ
Equillium Inc
$94.4M
HUMA
Humacyte Inc
$185.4M
IMDX
Insight Molecular Diagnostics Inc
$215.0M
PEPG
PepGen Inc
$447.6M
Earnings
Beat rate: 80.0%
Next Report
May 11, 2026
EPS Estimate: $-0.19
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.19 | — | — |
| Dec 2025 | $-0.19 | $-0.27 | $-0.08 |
| Sep 2025 | $-0.24 | $-0.15 | +$0.09 |
| Jun 2025 | $-0.25 | $-0.19 | +$0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 12.3% | 12.7% | 12.7% | 12.7% | 12.3% | 17.8% |
| P/E (TTM) | 10.09 | 10.27 | 14.57 | 15.26 | 14.04 | 6.44 |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.73 | 8.73 | 8.73 | 8.73 | 8.65 | 8.94 |
Key Ratios
ROA (TTM)
13.8%
P/B
1.5
EPS (TTM)
$0.36
CF/Share
$-2.09
52W High
$4.94
52W Low
$1.20
$1.20
52-Week Range
$4.94
How does BDTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BDTX valuation vs Biotechnology peers
P/E ratio
6.4
▼
66%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.5
▼
41%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BDTX profitability vs Biotechnology peers
ROE
17.8%
▲
126%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
13.8%
▲
130%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
BDTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.9
▲
101%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
3.3
▲
238%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
BDTX fundamentals radar
BDTX
Peer median
Industry
BDTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BDTX vs peers: key metrics
Latest News
No related news yet